ALK and neuroblastoma: Activating anaplastic lymphoma kinase (ALK) mutations are the most frequent mutations in NB, occurring in both familial and sporadic cases, with somatically acquired ALK mutations (ALKm) observed in 6%-12% of sporadic NBs in all risk groups.15-18